市场调查报告书
商品编码
1500246
医学写作市场:按类型、应用和最终用户划分 - 2024-2030 年全球预测Medical Writing Market by Type (Clinical Writing, Scientific Writing, Type Writing), Application (Medical Education, Medical Journalism, Medico Marketing), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年医学写作市场规模为61.5亿美元,预计2024年将达到68.7亿美元,2030年将达到136.8亿美元,复合年增长率为12.08%。
医学写作是一个专业的沟通领域,涉及清晰、简洁和准确地创建、综合和呈现复杂的医学资讯。它包括为医疗保健行业内不同相关人员(例如医疗保健专业人员、监管机构、患者和投资者)创建的各种格式的文件。医学撰稿人製作监管机构要求的综合文件,例如药物核准申请、临床实验试验方案、临床实验手册和总结报告,这些对于药物开发过程中所需材料的製作至关重要。此外,研究人员还可以使用方案、知情临床实验书、病例报告表(CRF)、临床试验报告(CSR)、摘要、海报、同行评审的期刊手稿和其他出版物来呈现临床试验结果。儘管具有广泛的使用潜力,但缺乏具有各种治疗领域技术知识的熟练专业人员限制了高级医学写作实践的提供。在处理敏感的患者资讯和专有研究资料时,维护机密性和资料隐私是该市场的一项挑战。市场相关人员正在努力改进处理患者个人资料时的安全程序,同时为作者提供一致的培训。自然语言处理(NLP)、人工智慧(AI)、机器学习(ML)和资料分析等新兴技术可能会塑造医学写作的未来模式。这些技术提供了自动化重复任务的机会,同时保持该领域所需的准确性水准。
主要市场统计 | |
---|---|
基准年[2023] | 61.5亿美元 |
预测年份 [2024] | 68.7亿美元 |
预测年份 [2030] | 136.8亿美元 |
复合年增长率(%) | 12.08% |
区域洞察
由于新药临床试验和监管备案数量的增加,製药和医疗保健行业的发展,美洲对医学写作的需求迅速增加。多家全球製药公司在欧洲拥有强大的影响力,这增加了对经验丰富的医学撰稿人的需求,他们能够根据监管要求有效地传达复杂的科学讯息。近年来,亚洲已成为临床研究的主要参与者,印度和中国等国家成为外包的热点。以具有竞争力的成本提供熟练的专业人员以及不断增加的政府支持正在推动这一不断增长的需求。此外,随着亚洲监管机构收紧临床试验资料报告指南和其他相关流程,我们预计许多公司将聘请专门的医学写作服务来确保合规性。欧洲拥有大量知名製药公司和研究机构,它们积极参与药物发现和开发过程,需要各种医学写作程序。欧洲药品管理局 (EMA) 等严格法规要求熟练的医学作家和类似软体的製作符合监管标准,例如安全性概况和功效报告。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在医学写作市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对医学写作市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在医学写作市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[188 Pages Report] The Medical Writing Market size was estimated at USD 6.15 billion in 2023 and expected to reach USD 6.87 billion in 2024, at a CAGR 12.08% to reach USD 13.68 billion by 2030.
Medical writing is a specialized field of communication that involves developing, synthesizing, and presenting complex medical information in a clear, concise, and accurate manner. It encompasses various forms of written material designed for different stakeholders within the healthcare industry, including healthcare professionals, regulatory agencies, patients, and investors. Medical writers develop comprehensive documents required by regulatory authorities, which are vital for creating drug approval applications, clinical trial protocols, investigational brochures, summary reports, and other materials needed throughout the drug development process. Additionally, it is used by researchers to create study protocols, informed consent forms, case report forms (CRFs), clinical study reports (CSRs), abstracts, posters, manuscripts for peer-reviewed journals, and other publications presenting clinical trial results. The scarcity of skilled professionals possessing technical knowledge about various therapeutic areas limits the provision of advanced medical writing practices despite their wide use potential. Maintaining confidentiality and data privacy when dealing with sensitive patient information or proprietary research data is a challenge for this market. Market players are working on providing consistent training for their writers while including improved safety procedures for handling the personal data of patients. Emerging technologies such as natural language processing (NLP), artificial intelligence (AI), machine learning (ML), and data analytics potentially shape the future landscape of medical writing. These technologies offer opportunities to automate repetitive tasks while preserving the accuracy levels required in this field.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.15 billion |
Estimated Year [2024] | USD 6.87 billion |
Forecast Year [2030] | USD 13.68 billion |
CAGR (%) | 12.08% |
Regional Insights
Medical writing has witnessed an upsurge in demand in the Americas due to the growing pharmaceutical and healthcare industries with an increasing number of clinical trials and regulatory submissions for novel therapies. Several global pharmaceutical companies have a strong presence in Europe, thus contributing to the demand for experienced medical writers to effectively communicate complex scientific information following regulatory requirements. In recent years, Asia has emerged as a significant player in clinical research, with countries such as India and China becoming hotspots for outsourcing medical writing services. The availability of skilled professionals at competitive costs combined with increasing government support has contributed to this rise in demand. Furthermore, as Asian regulators tighten clinical trial data reporting guidelines and other related processes in these countries, numerous corporations are expected to adopt specialized medical writing services to ensure compliance. Europe represents a strong presence of renowned pharmaceutical companies and research organizations actively involved in drug discovery & development processes, requiring various medical writing procedures. Strict regulations from agencies such as the European Medicines Agency (EMA) necessitate substantial documentation outlining safety profiles & efficacy reports that must comply with regulatory standards, thereby driving demand for skilled medical writers or similar software.
Market Insights
The market dynamics represent an ever-changing landscape of the Medical Writing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Writing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Writing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative
TrialAssure, a clinical trial disclosure, data sharing, and transparency SaaS provider, partnered with MMS, a global clinical research organization, to create an artificial intelligence (AI) initiative for medical writing in drug development. The partnership aimed to utilize AI-generated text specifically tailored for developing plain language summary (PLS) documents that enable effective communication of clinical findings to patients, families, and the public in an easily understandable manner. [Published On: 2023-08-03]
Catalyst Clinical Research Announces Acquisition of Genpro Research
Catalyst Clinical Research, a clinical research organization, recently expanded its global presence by acquiring Genpro Research. The acquisition strengthens Catalyst's position in the clinical research sector, significantly broadening its client base to include existing and potential customers in the biopharma, MedTech, and contract research organization (CRO) niches. Moreover, this strategic move adds over 120 skilled professionals from India to the Catalyst team with proficiency in biometrics and medical writing. [Published On: 2023-07-21]
ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
ProPharma Group (PPG), a global provider of clinical, regulatory, and quality services for the life sciences industry, announced the acquisition of Kateric, a globally renowned provider of outsourced medical writing and clinical trials disclosure support. This acquisition enabled ProPharma Group to significantly expand and enhance its comprehensive suite of medical writing services. [Published On: 2022-09-01]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Writing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medical Writing Market, highlighting leading vendors and their innovative profiles. These include Allucent, Ancillaire, Bioforum CDMC Ltd., Cactus Communications, Caidya, Cardinal Health, Cognizant Technology Solutions, Covance, Inc. by Labcorp, Emtex Life Science, Freyr, HCL Tech, Icon PLC, InClin, Inc., Indegene, IQVIA Holdings Inc., MakroCare, Merck & Co., North American Science Associates, LLC, Novartis AG, Parexel International Corporation by Phoenix Parentco, Inc., ProPharma Group, Quanticate, Rho, Inc., Scinopsis by Veristat, SIRO Clinpharm Private Limited, Synchrogenix, Tata Consultancy Services, Trilogy Writing & Consulting GmbH, Wipro Limited, and Xogene LLC.
Market Segmentation & Coverage